Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Adam Wheatley and Stephen Kent.
Adam Wheatley
Connection Strength
3.767
Stephen Kent
  1. Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19. Nat Commun. 2021 02 19; 12(1):1162.
    View in: PubMed
    Score: 0.930
  2. Decay of Fc-dependent antibody functions after mild to moderate COVID-19. Cell Rep Med. 2021 06 15; 2(6):100296.
    View in: PubMed
    Score: 0.236
  3. Hemagglutinin Functionalized Liposomal Vaccines Enhance Germinal Center and Follicular Helper T Cell Immunity. Adv Healthc Mater. 2021 05; 10(10):e2002142.
    View in: PubMed
    Score: 0.233
  4. Immunogenicity of prime-boost protein subunit vaccine strategies against SARS-CoV-2 in mice and macaques. Nat Commun. 2021 03 03; 12(1):1403.
    View in: PubMed
    Score: 0.233
  5. Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19. Nat Med. 2020 09; 26(9):1428-1434.
    View in: PubMed
    Score: 0.223
  6. Inducible Bronchus-Associated Lymphoid Tissues (iBALT) Serve as Sites of B Cell Selection and Maturation Following Influenza Infection in Mice. Front Immunol. 2019; 10:611.
    View in: PubMed
    Score: 0.204
  7. Immunological basis for enhanced immunity of nanoparticle vaccines. Expert Rev Vaccines. 2019 03; 18(3):269-280.
    View in: PubMed
    Score: 0.202
  8. Antibody-dependent phagocytosis (ADP) responses following trivalent inactivated influenza vaccination of younger and older adults. Vaccine. 2017 11 07; 35(47):6451-6458.
    View in: PubMed
    Score: 0.184
  9. Fc or not Fc; that is the question: Antibody Fc-receptor interactions are key to universal influenza vaccine design. Hum Vaccin Immunother. 2017 06 03; 13(6):1-9.
    View in: PubMed
    Score: 0.177
  10. Antibody-dependent cellular cytotoxicity and influenza virus. Curr Opin Virol. 2017 02; 22:89-96.
    View in: PubMed
    Score: 0.175
  11. Simultaneous evaluation of antibodies that inhibit SARS-CoV-2 variants via multiplex assay. JCI Insight. 2021 08 23; 6(16).
    View in: PubMed
    Score: 0.060
  12. Structural basis of biased T cell receptor recognition of an immunodominant HLA-A2 epitope of the SARS-CoV-2 spike protein. J Biol Chem. 2021 09; 297(3):101065.
    View in: PubMed
    Score: 0.060
  13. SARS-CoV-2-specific CD8+ T-cell responses and TCR signatures in the context of a prominent HLA-A*24:02 allomorph. Immunol Cell Biol. 2021 10; 99(9):990-1000.
    View in: PubMed
    Score: 0.060
  14. From influenza to COVID-19: Lipid nanoparticle mRNA vaccines at the frontiers of infectious diseases. Acta Biomater. 2021 09 01; 131:16-40.
    View in: PubMed
    Score: 0.059
  15. Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med. 2021 07; 27(7):1205-1211.
    View in: PubMed
    Score: 0.059
  16. Nanobody cocktails potently neutralize SARS-CoV-2 D614G N501Y variant and protect mice. Proc Natl Acad Sci U S A. 2021 05 11; 118(19).
    View in: PubMed
    Score: 0.059
  17. Prospects for durable immune control of SARS-CoV-2 and prevention of reinfection. Nat Rev Immunol. 2021 06; 21(6):395-404.
    View in: PubMed
    Score: 0.059
  18. CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity. Immunity. 2021 05 11; 54(5):1066-1082.e5.
    View in: PubMed
    Score: 0.059
  19. Systems serology detects functionally distinct coronavirus antibody features in children and elderly. Nat Commun. 2021 04 01; 12(1):2037.
    View in: PubMed
    Score: 0.059
  20. Adaptive immunity to human coronaviruses is widespread but low in magnitude. Clin Transl Immunology. 2021; 10(3):e1264.
    View in: PubMed
    Score: 0.058
  21. Robust correlations across six SARS-CoV-2 serology assays detecting distinct antibody features. Clin Transl Immunology. 2021; 10(3):e1258.
    View in: PubMed
    Score: 0.058
  22. Integrated immune dynamics define correlates of COVID-19 severity and antibody responses. Cell Rep Med. 2021 03 16; 2(3):100208.
    View in: PubMed
    Score: 0.058
  23. Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models. Nat Rev Immunol. 2020 12; 20(12):727-738.
    View in: PubMed
    Score: 0.057
  24. Suboptimal SARS-CoV-2-specific CD8+ T cell response associated with the prominent HLA-A*02:01 phenotype. Proc Natl Acad Sci U S A. 2020 09 29; 117(39):24384-24391.
    View in: PubMed
    Score: 0.056
  25. Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies. Nat Microbiol. 2020 10; 5(10):1185-1191.
    View in: PubMed
    Score: 0.056
  26. Circulating TFH cells, serological memory, and tissue compartmentalization shape human influenza-specific B cell immunity. Sci Transl Med. 2018 02 14; 10(428).
    View in: PubMed
    Score: 0.047
  27. Immunological Principles Guiding the Rational Design of Particles for Vaccine Delivery. ACS Nano. 2017 01 24; 11(1):54-68.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.